Abstract
Spontaneous Parkinsonism (SP) in schizophrenia-related disorders is poorly characterized. The objective of this study was to examine the concordance and clinical validity of alternative definitions of SP in patients with nonaffective psychotic disorders. Two-hundred drug-naive patients with nonaffective psychotic disorders were examined for core parkinsonian signs, including bradykinesia, rigidity, and tremor, and diagnosed of SP according to the Simpson-Angus Scale (SAS) cutoff criterion, the UK Parkinson’s disease brain bank (UKPDBB) criteria, the National Institute of Neurological Disorders and Stroke (NINDS) criteria, and criteria requiring the presence of all three core features (full syndrome criteria). Parkinsonian signs and criteria were examined in relation to a number of relevant clinical variables. The most frequent sign was rigidity (33.5%) followed by bradykinesia (16%) and tremor (12%). The prevalence rate of SP according to the SAS cutoff criterion, the UKPDBB criteria, the NINDS criteria for possible and probable SP, and the full syndrome criteria were 20.5, 13, 25.5, 18.5, and 4%, respectively. Bradykinesia was specifically related to negative symptoms, rigidity to neurological soft signs, and tremor to dyskinetic movements. The set of criteria showing more associations with clinical variables were the NINDS criteria for probable SP. Patients fulfilling these criteria had higher ratings for poor premorbid adjustment, negative symptoms, dyskinesia, neurological soft signs, and poor global treatment response than those without that diagnosis. The NINDS criteria for probable SP, i.e., presence of any two of the three core parkinsonian signs, seem to be the most suitable for clinical and research purposes.
Similar content being viewed by others
References
Kraepelin E (1913) Dementia Praecox and Paraphrenia (Trans: Barklay RM). Livingstone, Edinburgh
Wolff AS, O’Driscoll GA (1999) Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk. J Psychiatry Neurosci 24:304–314
Pappa S, Dazzan P (2009) Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychol Med 39:1065–1076
Whitty PF, Owoeye O, Waddington J (2009) Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 35:415–424
Peralta V, Campos MS, García de Jalón E, Cuesta MJ (2010) Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders. Mov Disord 25:1068–1076
Günther W, Günther R, Eich FX, Eben E (1986) Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. II Cross validation study on schizophrenic patients: persistence of a “psychotic motor syndrome” as possible evidence of an independent biological marker syndrome for schizophrenia. Eur Arch Psychiatry Clin Neurosci 235:301–308
Torrey F (2002) Studies of individuals with schizophrenia never treated with antipsychotic drugs: a review. Schizophr Res 58:101–115
Caligiuri MP, Lohr JB, Jeste DV (1993) Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry 150:1343–1348
Chatterjee A, Chakos M, Koreen A, Geisler S, Sheitman B, Woerner M, Kane JM, Alvir J, Lieberman JA (1995) Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 152:1724–1729
Honer WG, Kopala LC, Rabinowitz J (2005) Extrapyramidal symptoms and signs in first-episode, antipsychotic-exposed and non-exposed patients with schizophrenia or related psychotic illness. J Psychopharmachol 19:277–285
McCreadie RG, Padmavati R, Thara R, Srinivasan TN (2002) Spontaneous dyskinesia and Parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up. Br J Psychiatry 181:135–137
Cortese L, Caligiuri MP, Malla AK, Manchanda R, Takhar J, Haricharan R (2005) Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic naïve schizophrenia patients. Schizophr Res 75:65–75
Zielasek J, Gaebel W (2008) Modern modularity and the road towards a modular psychiatry. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):60–65
Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Arbizu J, Giménez-Amaya JM (2002) The basal ganglia and disorders of movement. News Physiol Sci 17:51–55
Hoeppner J, Prudente-Morrissey L, Herpertz SC, Benecke R, Walter U (2009) Substantia nigra hyperechogenicity in depressive subjects relates to motor assimetry and impaired word fluency. Eur Arch Psychiatry Clin Neurosci 259:92–97
Kuhn J, Gaebel W, Klosterkoetter J, Woopen C (2009) Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. Eur Arch Psychiatry Clin Neurosci 259(Suppl 2):135–141
Tuppurainen H, Kuikka JT, Laakso MP, Viinamäki H, Husso M, Tiihonen J (2006) Midbrain dopamine D2/3 receptor binding in schizophrenia. Eur Arch Psychiatry Clin Neurosci 256:382–387
Rogers D (1985) The motor disorders of severe psychiatric illness: a conflict of paradigms. Br J Psychiatry 147:221–232
Möller H-J, Müller H, Borison RL, Schooler NR, Chouinard G (1995) A path-analytical approach to differentiate between direct and indirect drug-effects on negative symptoms of schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 245:45–49
Peralta V, Cuesta MJ (2010) The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone or olanzapine. Prim Care Companion. J Clin Psychiatry 12:1–11
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
Andreasen NC, Flaum M, Arndt S (1992) The comprehensive assessment of symptoms and diagnosis. An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49:615–623
Peralta V, Cuesta MJ (2011) Neuromotor abnormalities in neuroleptic-naïve psychotic patients: antecedents, clinical correlates and prediction of treatment response. Comp Psychiatry 52:139–145
Harris JG (1975) Abbreviated form of the Phillips rating scale of premorbid adjustment in schizophrenia. J Abnorm Psychol 84:129–137
Perkins DO, Leserman J, Jarskog LF, Graham K, Kazmer J, Lieberman JA (2000) Characterizing and dating the onset of symptoms in psychotic illness: the symptom onset in schizophrenia (SOS) inventory. Schizophr Res 44:1–10
Guy W (1976) ECDEU assessment manual for psychopharmacology. Government Printing Office, US Washington
Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side-effects. Acta Psychiatr Scand 212(suppl. 44):11–19
Barnes TRE (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672–676
Lund CE, Mortimer AM, Rogers D, McKenna PJ (1991) Motor, volitional and behavioural disorders in schizophrenia 1: assessment using the modified Rogers scale. Br J Psychiatry 158:323–327
Buchanan RW, Heinrichs DW (1989) The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatr Res 27:335–350
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39
Grove WM, Andreasen NC (1982) Simultaneous test of many hypotheses in exploratory research. J Nerv Mental Dis 170:3–7
Hoehn MM, Yahr MD (1967) Parkinsonism. Onset, progression and mortality. Neurology 17:427–442
Reichmann H (2010) Clinical criteria for the diagnosis of Parkinson’s disease. Neurodegener Dis 7:284–290
Peralta V, Cuesta MJ (1999) Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res 40:245–253
Peralta V, Cuesta MJ, Martinez-Larrea A, Serrano JF (2000) Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment. Am J Psychiatry 157:1461–1466
Strous RD, Alvir JMG, Robinson D, Gal G, Sheirman B, Chakos, Lieberman JA (2004) Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects. Schizophr Bull 30:265–278
Jimenez-Jimenez F, Ortí-Pareja M, Ayuso-Peralta L, Gasalla T, Cabrera-Valdivia F, Vaquero A et al (1996) Drug-induced Parkinsonism in a movement disorder clinic. Parkinsonism Relat Disord 2:145–149
Geschwandtner U, Pflüger M, Aston J, Borgwardt S, Drewe M, Stieglitz R-D, Riecher-Rössler A (2006) Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 256:201–206
Acknowledgments
Funding for this study was provided by the Departmento de Salud del Gobierno de Navarra (grants 946/2005 and 55/2007) (M.J. Cuesta) and the Ministerio de Educación y Ciencia (SAF2008-05674-C03-02) (V. Peralta). The two funding agencies had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peralta, V., Basterra, V., Campos, M.S. et al. Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders. Eur Arch Psychiatry Clin Neurosci 262, 131–138 (2012). https://doi.org/10.1007/s00406-011-0219-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-011-0219-1